IMiDs and BET inhibitors target distinct pathways of MYC dysregulation by super-enhancers in multiple myelomaDaniel L. Riggs,Camille Herzog,Victoria M. Garbitt,Niamh Keane, Courtney J. Hillukka, Zachary J. Hammond,Julia E. Wiedmeier,Seth J. Welsh,Shulan Tian,Huihuang Yan,Ranjan Maity,Nizar Bahlis,Paola Neri,W. Michael Kuehl,Marta Chesi,P. Leif BergsagelCANCER RESEARCH(2019)引用 1|浏览28暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要